March 2011 - American College of Cardiology, ACC, invites Dr. David M. Schreck to present a poster abstract at the American College of Cardiology 60th Annual Scientific Session and i2 Summit, April 2-5, 2011, in New Orleans, LA, USA. Title of abstract is "Real-Time Cardiac Electrical Biomarker for Detection of AMI".
January 2011 - VectraCor is granted additional patent protection in India
VectraCor is granted additional patent protection in Japan - August 2010
VectraCor is granted additional patent protection in China - July 2010
Awards:
Best Electronics/Advanced Materials Company
VectraCor is Awarded the " Best Electronics/Advanced Materials Company" at the NJTC Venture Conference on March 25, 2011.
The New Jersey Technology Council provides business support, networking opportunities, information, advocacy and recognition of technology companies and their leaders.
First Place National Winner
VectraCor has been named the Top Emerging Company of Pitching Across America 2010
A panel of 100+ Venture Capital and Angel Investors acted as "judges" in this competition. There were 50 Top rated Companies selected from across the US, and
VectraCor was selected as the
Top Emerging Company in America.
http://www.fundingpost.com/paa-winners_2010.asp
The Society of Critical Care Medicine (SCCM) - Awards Dr. David Schreck as a recipient of the 2011 Annual Scientific Awards. The award will be formally presented during the Society's Poster Award Presentation to be held on Tuesday, January 18, 2011 from 1:00pm-1:30pm in Room 11 of the San Diego Convention Center in conjunction with the 40th Critical Care Congress. The award is intended to recognize excellence in critical care research. Dr. Schreck's abstract is Abstract #1, titled "Detection of Acute Myocardial Infarction Using a Real-Time Cardiac Electrical Biomarker". There were almost 1200 abstracts reviewed.
VectraCor is Awarded the " Judges Choice Award" at the NJTC Venture Conference on March 26, 2010.
The New Jersey Technology Council provides business support, networking opportunities, information, advocacy and recognition of technology companies and their leaders.
VectraCor is awarded grant from The Commission on Science and Technology from the State of New Jersey. The Edison Innovation R&D Fund will provide grants on a competitive basis. In November 2009, The Edison Innovation R&D Fund notified VectraCor and 7 other companies of their award. The grant ranges from $100,000 to $500,000, which VectraCor is pleased to receive a $500,000 grant. The grant is to develop an ambulatory holter monitoring system that incorporates VectraCor's proprietary IP.
Events and Meetings:
American College of Cardiology (ACC)
Chicago, IL
March 24-26, 2012
Booth 20091
International CES 2012 - Consumer Electronics Show:
Las Vegas, NV
January 10-13, 2012
Verizon Wireless Booth #30259
Verizon is featuring the Vectraplex Holter System under Development in their booth.
American Heart Association
Orlando, Florida
November 13-15th, 2011
Booth #935
April 3-5, 2011
American College of Cardiology (ACC)
New Orleans Convention Center
March 25, 2011
NJTC Venture Conference
The Palace at Somerset Park, NJ
February 3, 2011 - VectraCor has been chosen to present at New Jersey Technology Council's Life Science Research Symposium. The meeting is at Kean University in Union, NJ. Presentations start at 5:00pm on February 3, 2011.
Society of Critical Medicine (SCCM)
San Diego Convention Center
San Diego, California
January 16th-18th, 2011